WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke ADVANCE THE CELL & GENE THERAPY COLLECTIVE wurde als Wortmarke am 04.10.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1568388 |
| Länder | 
|
| Basismarke |
Nr. 90226712,
30. September 2020
|
| Anmeldedatum | 04. Oktober 2020 |
| Ablaufdatum | 01. August 2022 |
Markeninhaber
2 Bethesda Metro Center, Suite 850
Bethesda MD 20814
US
Bethesda MD 20814
US
Markenvertreter
422 Morris Ave
Summit NJ 07901
US
Waren und Dienstleistungen
35
Business management consulting services to the
pharmaceutical and life sciences companies to provide advice
and business strategies to conduct and manage research and
clinical development of targeted therapies and diagnostics,
clinical solutions, regulatory guidance, health economics
design, launch planning, access strategy, promotional
effectiveness, and market adoption; business management
consultation in the field of promotion opportunity
assessment, promotion effectiveness, payer promotion
strategy, account manager and sales force promotion strategy
and distribution strategy; business and management
consulting services in the fields of healthcare,
pharmaceuticals, biotechnology, medical devices, food and
nutrition; public policy consulting services in the fields
of healthcare, pharmaceuticals, biotechnology, medical
devices, food and nutrition; business services provided to
the healthcare industry, namely, the creation, collection,
analysis, and reporting of health care data and information
for support of business and public policy decision-making;
provision of statistical and commercial and business
information in the fields of healthcare, pharmaceuticals,
biotechnology, medical devices, health insurance, food and
nutrition
41
Providing online electronic publications, not downloadable,
in the nature of informational reports for support of
business and policy decisions for the healthcare industry
42
Scientific consulting services in the fields of healthcare,
pharmaceuticals, biotechnology, medical devices, food and
nutrition; scientific consulting services for the health
insurance industry; provision of scientific research
information in the fields of healthcare, pharmaceuticals,
biotechnology, medical devices, health insurance, food and
nutrition; providing medical and scientific research
information in the field of clinical trials as they relate
to healthcare, pharmaceuticals, biotechnology, medical
devices and food and nutrition
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 15. März 2023 | 2023/16 Gaz | US | RAW: Total Ceasing Effect |
| 24. Januar 2023 | 2023/5 Gaz | CA | Ablehnung |
| 13. April 2022 | 2022/15 Gaz | CA | Ablehnung |
| 12. August 2021 | 2021/32 Gaz | GB | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 11. Juni 2021 | 2021/25 Gaz | Löschung | |
| 12. März 2021 | 2021/11 Gaz | GB | Ablehnung |
| 29. Januar 2021 | 2021/6 Gaz | EM | Ablehnung |
| 04. Oktober 2020 | 2020/51 Gaz | US | Eintragung |
ID: 141568388